“…These individuals display high levels of insulin sensitivity, favorable inflammation and lipid profiles, and a low prevalence of hypertension, and are hypothesized to be protected from, or to be at substantially lower risk of, obesity-related metabolic complications, including cardiovascular diseases, type 2 diabetes, and mortality (2)(3)(4)(5)(6)(7). There is no consensus on the definition of so-called ''healthy obesity,'' and researchers have generally used insulin sensitivity denoted by low HOMA-IR, absence of metabolic syndrome (MetS) 9 , or a combination of both, to describe the phenotype (2)(3)(4)(5). MetS is a multiplex of metabolic risk factors that includes abdominal obesity, elevated blood pressure, hyperglycemia, low HDL cholesterol, and hypertriglyceridemia (8).…”